Alaunos Therapeutics reported $1.29M in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
Alaunos Therapeutics USD 1.29M 865K Mar/2026
Amgen USD 11.69B 2.5B Jun/2026
AstraZeneca USD 50.3B 2.96B Jun/2026
Baxter International USD 6.21B 163M Jun/2026
Biogen USD 18.85B 196.3M Jun/2026
Bioline Rx USD 20.83M 2.64M Mar/2026
Bristol-Myers Squibb USD 22.32B 2.25B Jun/2026
Celltrion KRW 434.82B 1.14B Mar/2026
Corcept Therapeutics USD 705.78M 67.79M Jun/2026
Cspc Pharmaceutical CNY 33.18B 71.46M Dec/2025
Curis USD 12.71M 7.24M Mar/2026
Deva Holding AS TRY 5.79B 604.07M Sep/2023
Dianthus Therapeutics USD 1.17B 29.29M Jun/2026
Divis Laboratories Ltd INR 167.61B 13.48B Mar/2026
Gilead Sciences USD 11.74B 11.77B Jun/2026
GlaxoSmithKline GBP 17.64B 223M Jun/2026
Incyte USD 6.34B 721.58M Jun/2026
Intrexon USD 43.17M 75.33M Jun/2024
Ionis Pharmaceuticals USD 439.74M 51.68M Jun/2026
J&J USD 84.97B 3.78B Jun/2026
Kangmei Pharma CNY 7.31B 84.82M Mar/2026
Karyopharm Therapeutics USD -265.65M 27.28M Mar/2026
Knight Therapeutics CAD 767.27M 480K Dec/2025
Laboratorios Farma EUR 539.39M 22.74M Dec/2023
Malin Corporation EUR 193.2M 75M Dec/2024
Medical Developments International AUD 54.77M 335K Dec/2025
Merck USD 41.93B 3.94B Jun/2026
Neuren Pharmaceuticals AUD 338.45M 15.18M Dec/2025
Novartis USD 41.95B 3.02B Jun/2026
Organigram Holdings CAD 371.81M 2.36M Mar/2026
Ovoca Bio EUR 780K 485K Dec/2025
Pfizer USD 85.19B 4.91B Jun/2026
Pharma Mar EUR 250.77M 1.1M Jun/2026
PTC Therapeutics USD -165.36M 15.1M Jun/2026
Qiagen NV USD 3.33B 446.45M Mar/2026
Regeneron Pharmaceuticals USD 31.71B 287.8M Jun/2026
Roche Holding CHF 32.69B 1.11B Jun/2026
Sangamo BioSciences USD 19.6M 14.7M Jun/2025
Sartorius EUR 2.82B 96.3M Jun/2026
Sino Biopharmaceutical CNY 34B 1.48B Jun/2025
TG Therapeutics USD 604.08M 20.95M Jun/2026
Tilray USD 1.58B 39.08M Sep/2025
Verastem USD 81.78M 24.58M Mar/2026
Zealand Pharma A/S 14.47B 361.61M Mar/2026
Zz Pientze Pharmaceu CNY 15.21B 740.32M Mar/2026